Anaplastic Astrocytoma

Pediatric Long-Term Follow-up and Rollover Study

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Targeted Pediatric High-Grade Glioma Therapy

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas

Study of Pembrolizumab and M032 (NSC 733972)

INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Loupe-Based Intraoperative Fluorescence Imaging